17th Apr 2018 07:00
AMENDMENT
INCREASED EQUITY PURCHASES BY 261,101 TO 5,149,022
INCREASED EQUITY SALES BY 141,621 TO 4,852,377
ADDED EQUITY SWAP PURCHASES OF 944,133
ADDED EQUITY SWAP SALES OF 1,933,186
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: | J.P. Morgan Securities Plc |
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree | Shire plc |
(c) Name of the party to the offer with which exempt principal trader is connected: | Joint Financial Adviser to Takeda Pharmaceutical Company Limited |
(d) Date dealing undertaken: | 28 March 2018 |
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" | Yes, Takeda Pharmaceutical Company Limited
|
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security | Purchases/ sales
| Total number of securities | Highest price per unit paid/received (GBP) | Lowest price per unit paid/received (GBP) |
Ordinary Shares | Purchases
Sales | 5,149,022
4,852,377 | 38.4450
38.5050 | 31.5100
31.5500 |
(b) Cash-settled derivative transactions
Class of relevant security | Product description e.g. CFD | Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position | Number of reference securities | Price per unit (GBP) |
Ordinary Shares | Equity Swap | Long
Short | 104 312 520 1,621 492 745 139 5,003 7,789 9,300 5,013 2,651 4,593 1,516 3,511 342 2,517 21,310 8,293 14,790 5,996 286 43,013 8 25 313 12 10,763 5,786 3,744 31,014 1,555 127,680 7,268 4,158 4,207 3,950 3,597 16,300 2,000 1,683 31 49 78 2,348 3,299 3,616 82 59 332,143 3,319 438 1,880 2,438 1,226 2,879 1,871 85 21,319 5,198 8,192 75 2,227 1,164 57 25 705 1,115 91,965 10 40,000 349 19,525 119 149 6,039 232 10,197 15,711
1,000 1,000 14 3,844 2 2 13 13 369 116 5 26 5,537 8 1,075 132 2,454 6,944 1,335 1,440 110 17,477 11,820 3,024 10,273 14,510 640 5,000 39 40,359 22,999 1,808 229 4,909 2,645 40,000 161 2,362 5,195 1,000 10,000 14,445 93 10,000 408 1,200,000 93,638 1,180 373 449 105 100,000 5,930 100,000 440 751 184 84 376 2,000 12,700 1,182 25,214 23,356 4,254 1,658 96,101 17,274 687 415 | 31.5891 31.6057 31.6291 31.6545 31.8125 31.8417 31.8454 31.9289 31.9985 32.1448 32.2719 32.7528 32.7532 33.1132 33.4779 33.6698 33.8479 33.9925 34.1764 34.2989 34.8677 34.8898 34.9163 34.9741 34.9791 34.9874 34.9991 35.0578 35.0661 35.0720 35.0950 35.1377 35.2102 35.3266 35.3333 35.3570 35.3929 35.4170 35.5707 35.6966 35.7288 35.7914 35.7963 35.8317 35.8361 35.8398 35.8458 35.9139 35.9245 35.9265 35.9279 35.9335 35.9455 35.9565 35.9663 35.9986 36.0115 36.0121 36.0240 36.0347 36.0849 36.1037 36.1820 36.2342 36.2543 36.3810 36.4230 36.4754 36.5271 36.5499 36.6418 36.6970 36.7097 36.9756 37.1442 37.1883 37.3888 37.4684 37.8128
31.5195 31.7095 31.8086 31.8127 31.8180 31.8419 31.8599 31.8680 31.8760 31.8885 31.9942 31.9977 32.0052 32.0584 32.1736 32.2000 32.4353 33.5001 33.6526 33.7368 34.2274 34.4683 34.5446 34.5669 34.6778 34.7075 34.7634 34.9360 34.9671 35.0002 35.0016 35.0036 35.0079 35.0148 35.0185 35.0347 35.0661 35.0799 35.2479 35.2502 35.2738 35.2744 35.3311 35.3322 35.4214 35.5886 35.5923 35.6077 35.6356 35.6540 35.6736 35.6751 35.8225 35.8793 35.9095 35.9099 35.9611 36.0211 36.0959 36.0990 36.1434 36.3463 36.3682 36.3704 36.3711 36.5217 36.6558 36.9282 36.9688 37.0456 |
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security | Product description e.g. call option | Writing, purchasing, selling, varying etc. | Number of securities to which option relates | Exercise price per unit (GBP) | Type e.g. American, European etc. | Expiry date | Option money paid/ received per unit (GBP) |
(ii) Exercise
Class of relevant security | Product description e.g. call option | Exercising/ exercised against | Number of securities | Exercise price per unit (GBP) |
|
(d) Other dealings (including subscribing for new securities)
Class of relevant security | Nature of dealing e.g. subscription, conversion | Details | Price per unit (if applicable) (GBP) |
|
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" |
None
|
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" |
None
|
| Date of disclosure: | 16 April 2018 |
| Contact name: | Alwyn Basch |
| Telephone number: | 020 7742 7407 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
Related Shares:
Shire